| Financial Year |
March 31 2023 |
| Monetary Funds |
1,331,909,969.09 |
| Held-for-trading Financial Assets |
62,619,785.17 |
| Notes Receivable |
66,441,498.14 |
| Accounts Receivable |
1,089,824,731.64 |
| Advances to Suppliers |
40,159,964.11 |
| Other Receivables |
39,852,472.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
964,218,245.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
92,382,570.02 |
| Other Current Assets |
7,591,007.94 |
| Total Current Assets |
3,725,120,324.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
54,861,164.11 |
| Investment Properties |
-- |
| Fixed Assetes |
2,084,439,919.52 |
| Under-construction Projects |
829,068,649.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
363,706,366.90 |
| R&D expenses |
-- |
| Goodwill |
8,518,487.47 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
60,997,972.42 |
| Other Non-Current Assets |
846,456,013.39 |
| Sub-Total of Non-Current Assets |
4,286,696,495.02 |
| Total Assets |
8,011,816,819.58 |
| Short-Term Loans |
1,293,955,875.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,500,000.00 |
| Accounts Payable |
968,946,959.79 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
125,819,220.24 |
| Taxes Payable |
53,783,375.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
329,011,097.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,687,322.52 |
| Other Current Liabilities |
56,467,274.11 |
| Sub-Total of Current Liabilities |
3,172,640,410.15 |
| Long-term Loans |
227,233,552.59 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,959,115.05 |
| Deferred Income Tax Liabilities |
9,525,285.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
356,246,919.18 |
| Total Liabilities |
3,528,887,329.33 |
| Paid-In Capital(Or Share Stock) |
486,039,976.00 |
| Capital Surplus |
1,342,493,224.82 |
| Surplus Reserve |
298,582,739.06 |
| LESS:Treasury Stock |
134,499,108.26 |
| Undistributed Profits |
2,373,482,807.34 |
| Minority Stockholder's Interest |
111,843,593.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,371,085,897.22 |
| Owner's Equity（Stockholder's Equity） |
4,482,929,490.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,011,816,819.58 |
